The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Rennie Peppermint 680mg/80mg Chewable Tablets

680 mg/80 milligram(s) Chewable tablet

Bayer LimitedPA1410/053/001

Main Information

Trade NameRennie Peppermint 680mg/80mg Chewable Tablets
Active SubstancesCalcium carbonate
Magnesium carbonate
Strength680 mg/80 milligram(s)
Dosage FormChewable tablet
Licence HolderBayer Limited
Licence NumberPA1410/053/001

Group Information

ATC CodeA02AD Combinations and complexes of aluminium, calcium and magnesium compounds
A02AD01 ordinary salt combinations

Status

Authorised/WithdrawnAuthorised
Licence Issued01/04/1983
Legal statusProduct not subject to medical prescription
Supply StatusSupply through non-pharmacy outlets and pharmacies
Advertising StatusAdvertising to the general public
Conditions of Licence1. If you are taking medication, suffer from kidney disease or are under a doctor’s care, consult him before using. 2. If symptoms persist, consult the doctor. 3. Do not exceed the stated dose.
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportPDF Version
« Back